Philippe Robin
Gif-sur-yvette, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
The chemokine receptor-like fourth extracellular loop of the apelin receptor differentially regulates apelin and elabela binding and signalling.
Journal: British journal of pharmacology
Published: March 17, 2026
Synthesis and Pharmacological Characterization of Fluorescent Ligands Targeting the Angiotensin II Receptors Derived from Agonists, β-Arrestin-Biased Agonists, and Antagonists.
Journal: Journal of medicinal chemistry
Published: November 11, 2024
A Snake Toxin Derivative for Treatment of Hyponatremia and Polycystic Kidney Diseases.
Journal: Journal of the American Society of Nephrology : JASN
Published: May 01, 2024
Dosimetry for targeted radionuclide therapy in routine clinical practice: experts advice vs. clinical evidence.
Journal: European journal of nuclear medicine and molecular imaging
Published: December 19, 2023
Characterization of the First Animal Toxin Acting as an Antagonist on AT1 Receptor.
Journal: International journal of molecular sciences
Published: December 15, 2022
Apelin as a new therapeutic hope for cardiovascular diseases
Journal: Medecine sciences : M/S
Published: March 25, 2022
MT9, a natural peptide from black mamba venom antagonizes the muscarinic type 2 receptor and reverses the M2R-agonist-induced relaxation in rat and human arteries.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: March 15, 2022
Structural and Functional Diversity of Animal Toxins Interacting With GPCRs.
Journal: Frontiers in molecular biosciences
Published: November 08, 2021
A snake toxin as a theranostic agent for the type 2 vasopressin receptor.
Journal: Theranostics
Published: April 27, 2020
Alamandine, a molecule of therapeutic interest against cardiac hypertrophy
Journal: Medecine sciences : M/S
Published: March 05, 2020
Last Updated: 09/26/2026